首页> 外文期刊>Journal of the American College of Surgeons >An Evolving Story of Translational Research: A?Decade after the Jacobson Promising Investigator Award
【24h】

An Evolving Story of Translational Research: A?Decade after the Jacobson Promising Investigator Award

机译:翻译研究的不断发展的故事:a?雅各布森承诺调查员奖的十年

获取原文
获取原文并翻译 | 示例
           

摘要

The Third Joan L and Julius H Jacobson Promising Investigator Awardee, Mark Puder, MD, PhD, FACS In 2005, the Surgical Research Committee (SRC) of the American College of Surgeons was tasked with selecting the recipient of a newly established award, “The Joan L and Julius H Jacobson Promising Investigator Award.” According to the Jacobsons, the award, funded by Dr Jacobson, should be given at least once every 2 years to a surgeon investigator at “the tipping point,” who can demonstrate that his or her research shows the promise of leading to a significant contribution to the practice of surgery and patient safety. Every year, the SRC receives many excellent nominations and has the difficult task of selecting 1 awardee. The first awardee was Michael Longaker, MD, FACS, who, 10 years later, reflected on the award and the impact it had on his career. This year, Mark Puder, MD, PhD FACS, the third Jacobson awardee, reflects on his 10-year journey after receiving the award. Dr Puder is now a national and international figure in the field of intestinal failure-associated liver disease and has studied the effect of intravenous lipid emulsions on the etiology and treatment of a once fatal disease in children. Kamal MF Itani, MD, FACS and Brian S Zuckerbraun, MD, FACS, on behalf of the Research Committee of the American College of Surgeons.
机译:第三琼L和朱利叶斯H雅各逊有前途的调查员获奖者,Mark Puder,MD,博士,2005年的FACS,美国外科医生的外科学院(SRC)被任务选择了新成立的奖项的收件人“The琼L和朱利叶斯H雅各逊有前途的调查员奖。“根据Jacobsons,由雅加森博士资助的奖项应至少每2年给予一次外科医生调查员,以“倾倒点”,谁可以证明他或她的研究表明了导致重要贡献的承诺对手术和患者安全的做法。每年,SRC都会收到许多优秀提名,并具有选择1届奖项的艰巨任务。第一届奖杯是Michael Longaker,MD,Facs,10年后,反映了奖项和它对他职业生涯的影响。今年,Mark Puder,MD,第三次雅各布森奖人,博士博览会,反映了他收到奖项后的10年的旅程。 Puder博士现在是肠道失败相关肝病领域的国家和国际人物,并研究了静脉内脂乳液对儿童致命疾病的病因和治疗的影响。 Kamal MF Itani,MD,FACS和Brian S Zuckerbraun,MD,FACS代表美国外科医院研究委员会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号